Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Treatment Interruption”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00158405
What this trial is testing

Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 840
Early research (Phase 1)Active Not RecruitingNCT06006546
What this trial is testing

The Study of Immunization in People Living With HIV Undergoing an ATI for Elicitation of VRC01-lineage Antibodies

Who this might be right for
Chronic HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 35
Testing effectiveness (Phase 2)Study completedNCT00011011
What this trial is testing

Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 94
Not applicableStudy completedNCT00188851
What this trial is testing

Structured Treatment Interruption for HIV Patients With Virologic Failure

Who this might be right for
HIV
University Health Network, Toronto 196
Not applicableUnknownNCT05482854
What this trial is testing

Assessment of HIV Remission Upon cART Interruption in Early Treated Individuals Carrying the MHC B35/53Bw4TTC2 Genotype

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 50
Early research (Phase 1)Study completedNCT04385875
What this trial is testing

Study to Assess the Safety and Durability of Viral Control Beyond 24 Weeks of Analytical Treatment Interruption After the Administration of Candidate HIV-1 Vaccines DNA.HTI, MVA.HTI and ChAdOx1.HTI or Placebo in Early Treated HIV-1 Positive Individuals (ATI Extension of AELIX-002 Study)

Who this might be right for
HIV-1 Infection
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 6
Not applicableLooking for participantsNCT04359186
What this trial is testing

SCOPE Analytic Treatment Interruption Protocol

Who this might be right for
HIV/AIDS
University of California, San Francisco 40
Not applicableStudy completedNCT00311688
What this trial is testing

Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2 Studies

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00013663
What this trial is testing

Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 92
Post-approval studies (Phase 4)Study completedNCT00187551
What this trial is testing

Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance

Who this might be right for
HIV Infections
University of California, San Francisco 25
Early research (Phase 1)UnknownNCT05786937
What this trial is testing

Therapeutic Vaccine Based on aDC1 Dendritic Cells for the Control of Viremia After ATI in HIV Infected Individuals

Who this might be right for
HIV Vaccine
University of Sao Paulo General Hospital 30
Not applicableEnrolling By InvitationNCT02437526
What this trial is testing

Analytic Treatment Interruption (ATI) to Assess HIV Cure

Who this might be right for
HIV
Mayo Clinic 10
Not applicableStudy completedNCT00050063
What this trial is testing

Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 78
Early research (Phase 1)Study completedNCT03526848
What this trial is testing

3BNC117 and 10-1074 in ART-treated Individuals

Who this might be right for
Human Immunodeficiency Virus
Rockefeller University 26
Not applicableStudy completedNCT00005915
What this trial is testing

A Comparison of Two Anti-HIV Treatment Plans

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 480
Not applicableLooking for participantsNCT07329166
What this trial is testing

Reducing Mobility-associated Interruption in HIV Treatment in Malawi

Who this might be right for
HIV
University of California, Los Angeles 400
Testing effectiveness (Phase 2)Study completedNCT00672191
What this trial is testing

Phase II Study of AGS-004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV

Who this might be right for
HIV Infections
Argos Therapeutics 59
Early research (Phase 1)Temporarily pausedNCT07217379
What this trial is testing

The DART DELIVER-02 Study

Who this might be right for
HIV (Human Immunodeficiency Virus)
University of North Carolina, Chapel Hill 24
Testing effectiveness (Phase 2)Study completedNCT00029341
What this trial is testing

Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Testing effectiveness (Phase 2)Study completedNCT01492985
What this trial is testing

Lipopeptide Immunisation With GTU-multiHIV Trial

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 103
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation